Here are 10 anesthesiologists that made headlines in January 2018.
Anesthesia
Milwaukee-based Aurora St. Luke's Medical Center ended its partnership with Milwaukee-based Anesthesiology Associates of Wisconsin opting to partner with parent organization Aurora Health Care's own physician group, the Milwaukee Business Journal reports.
After Purdue Pharma said it would stop marketing opioid drugs to physicians, Bangor, Maine-based Penobscot Community Health Care Vice President Noah Nesin, MD, said the decision was "20 years late to the game," NPR reports.
Somnia Anesthesia made a series of appointments to its leadership team.
Pairing anesthesiology with a general surgery rotation improves medical students' knowledge of perioperative medicine, a study in Advances in Medical Education and Practice found.
The American Health Council appointed Michael Mahla, MD, to its board of physicians.
The global postoperative pain management market is expected to grow at a compound annual growth rate of 5.4 percent between 2017 and 2023, according to a report by Market Research Future.
OxyContin manufacturer Purdue Pharma will stop marketing opioid drugs to physicians, bowing to lawsuits that blame the company's sales efforts for helping trigger the current opioid epidemic, the Chicago Tribune reports.
San Antonio-based Methodist Hospital added Cris Johnson, MD, to its palliative care team.
The FDA released a statement warning that the popular herbal supplement kratom has opioid properties and is not a safe alternative to prescription opioids.
